Interventions for women with endometrioma prior to assisted reproductive technology

Authors: Harlow, Keryn; Igbokwe, Nnadozie; Bortoletto, Pietro; Farquhar, Cindy; Duffy, James Mn; Craciunas, Laurentiu

Source journal: The Cochrane database of systematic reviews (2026-11-17)

DOI: 10.1002/14651858.CD008571.pub3

Abstract

RATIONALE: The link between endometriosis and infertility has been firmly established; however, the mechanism remains controversial. Management of ovarian endometriosis (endometrioma) in the context of assisted reproductive technology (ART) varies greatly both in regard to the intervention chosen or, indeed, the decision to treat at all. Management remains a key clinical decision for patients requiring fertility treatment and guidance from scientific evidence is vital. This is an update of a Cochrane review first published in 2010. OBJECTIVES: To assess the effects of surgery, medical treatment, combination therapy (both medical and surgical) or no treatment for improving reproductive outcomes among women with endometrioma, prior to undergoing ART cycles. SEARCH METHODS: We searched the Cochrane Gynaecology and Fertility Group's specialised register, CENTRAL, MEDLINE, Embase and PsycINFO on 7 October 2025. We also searched trial registries, checked reference lists of relevant studies and contacted experts in the field for any additional trials. ELIGIBILITY CRITERIA: We selected randomised controlled trials (RCTs) that compared any medical and/or surgical intervention with another medical and/or surgical intervention or placebo/no intervention for the treatment of endometrioma prior to ART. The included population was women with endometrioma diagnosed by laparoscopy or pelvic imaging such as ultrasound, computed tomography (CT), or magnetic-resonance imaging (MRI). OUTCOMES: Our critical outcomes of interest, as presented in the summary of findings tables, were: live birth and adverse events. RISK OF BIAS: We used the Cochrane RoB 1 tool to assess bias in the included studies. SYNTHESIS METHODS: Due to significant heterogeneity between the included studies, we synthesised the results into a narrative review. We summarised key findings from individual studies descriptively and we structured them by outcome domain. We used GRADE to assess the certainty of evidence for the critical outcomes. INCLUDED STUDIES: We included a total of seven parallel-arm RCTs with 646 participants randomised. Two studies (173 participants) evaluated medical interventions and five studies (473 participants) evaluated surgical interventions for endometrioma prior to ART. No studies evaluated combination therapy. SYNTHESIS OF RESULTS: No clear benefit was found for any treatment over no treatment. We judged all studies to have a high or unclear risk of bias in at least two domains and graded the evidence as very low certainty as a result of this and imprecision due to low study numbers and wide confidence intervals. Below we report the critical outcomes, as presented in the summary of findings tables. Medical intervention: GnRH agonist protocol compared to control for ART The evidence is very uncertain about the effect of a GnRH agonist protocol compared to control on live birth (OR 3.70, 95% CI 1.25 to 10.90; 1 study, 64 participants; very low-certainty evidence). Adverse events were not reported. Surgical intervention (s): Endometrioma aspiration versus no aspiration The evidence is very uncertain about the effect of endometrioma aspiration compared to control on live birth (OR 1.66, 95% CI 0.59 to 4.62; 1 study, 81 participants; very low-certainty evidence). Adverse events were not reported. Endometrioma cystectomy versus no cystectomy The evidence is very uncertain about the effect of endometrioma cystectomy compared to control on live birth (OR 1.97, 95% CI 0.71 to 5.49; 1 study, 73 participants; very low-certainty evidence). Zero adverse events were reported in each study arm (1 study, 73 participants; very low-certainty evidence). Endometrioma transvaginal sclerotherapy versus no sclerotherapy No included study assessed live birth. Adverse events were not reported. AUTHORS' CONCLUSIONS: This narrative review highlights the uncertainties regarding the management of endometrioma prior to ART. There is no high-certainty evidence that might change the current guidance for management plans to be developed on an individual basis, taking into account previous outcomes, ovarian reserve, and patient's wishes. Further robust, adequately powered studies are required to guide future clinical decision-making which include critical outcomes as per the core outcome set for endometriosis. FUNDING: This Cochrane review had no dedicated funding. REGISTRATION: Protocol (2010) https://doi.org/10.1002/14651858.CD008571. Original review (2010) https://doi.org/10.1002/14651858.CD008571.pub2.

Read the full text

Related topics

Related open access articles

Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.